CAS 1476-53-5: Novobiocin sodium
Description:Novobiocin sodium, with the CAS number 1476-53-5, is an antibiotic compound that belongs to the class of coumarin derivatives. It is primarily derived from the bacterium *Streptomyces niveus* and exhibits antibacterial properties, particularly against Gram-positive bacteria. Novobiocin functions by inhibiting bacterial DNA gyrase, an enzyme critical for DNA replication and transcription, thereby disrupting bacterial growth. The sodium salt form enhances its solubility in aqueous solutions, making it suitable for various pharmaceutical applications. In addition to its antibacterial activity, novobiocin has been studied for its potential use in cancer therapy due to its ability to inhibit certain cellular processes. The compound is typically administered in a clinical setting and is subject to specific dosage guidelines due to its pharmacological effects. Safety and efficacy profiles are essential considerations in its use, as with any antibiotic, to prevent resistance development and ensure optimal therapeutic outcomes.
Formula:C31H36N2O11·Na
InChI:InChI=1S/C31H36N2O11.Na/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29;/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37);/t23-,25+,26-,29-;/m1./s1
InChI key:InChIKey=BZFOBLOAMAJKQV-RNROJPEYSA-N
SMILES:[Na].O=C(OC1C(O)C(OC=2C=CC=3C(O)=C(NC(=O)C4=CC=C(O)C(=C4)CC=C(C)C)C(=O)OC3C2C)OC(C)(C)C1OC)N
- Synonyms:
- (3R,4S,5R,6R)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]amino}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate (non-preferred name)
- 5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]amino}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate (non-preferred name)
- Albamycin
- Albamycin (capsule)
- Albamycin sodium
- Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-, sodium salt (1:1)
- Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl)-, monosodium salt
- Cathomycin sodium
- Cathomycin sodium lyovac
- Monosodium novobiocin
- See more synonyms
- N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide
- NSC 2382
- Novobiocin Sodium
- Novobiocin Sodium Crystalline
- Novobiocin Sodium Usp
- Novobiocin monosodium
- Novobiocin, monosodium salt
- Novobiocin, sodium deriv.
- Sodium albamycin
- Sodium novobiocin
- Vulcamycin
- sodium 7-{[(2R,3R,4S,5R)-4-(carbamoyloxy)-3-hydroxy-5-methoxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3-({[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]carbonyl}amino)-8-methyl-2-oxo-2H-chromen-4-olate (non-preferred name)
- Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-α-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl)-, monosodium salt
- Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-α-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-, sodium salt (1:1)
